It has been suggested that p53 gene mutation is a significant and independent predictor of poor prognosis in CRC (Russo et al, 2005), but we lack validation in prospective clinical trials as a marker for the assessment of prognosis in CRC patients (Hoff, 2005). The gene discussed is TP53; the disease is colorectal carcinoma.